← Back to Clinical Trials
RecruitingNCT06630845

Comparison of Whole Body DWI to FDG PET

Trial Parameters

ConditionMetastatic Cancer
SponsorUniversity of California, San Francisco
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment30
SexALL
Min Age18 Years
Max AgeN/A
Start Date2025-02-06
Completion2027-10-31
Interventions
Fluorodeoxyglucose F18Positron Emission Tomography combined with Magnetic resonance imaging (PET/MRI)Whole Body Magnetic Resonance Imaging with Diffusion-Weighted Imaging (WB-MRI-DWI)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is a single arm prospective trial that evaluates whole body diffusion weight imaging (DWI) compared to 18F-fludeoxyglucose (FDG) Positron Emission Tomography with Magnetic resonance imaging (PET/MRI) in participants with known metastatic cancer.

Eligibility Criteria

Inclusion Criteria: 1. Age ≥ 18 years. 2. Non FDG PET imaging study scheduled to be performed within 60 days (before or after) of the research PET/MRI. 3. Ability to understand a written informed consent document, and the willingness to sign it. 4. Diagnosis of metastatic cancer. Exclusion Criteria: 1. Unlikely to comply with protocol procedures, restrictions and requirements and judged by the Investigator to be unsuitable for participation. 2. Individuals with contraindications to MRI. This will be determined through review of the UCSF MRI screening form by qualified site personnel

Related Trials